XML 84 R42.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Intangible Assets - License Agreements (Details) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017
Sales and Marketing Expense |  |  |
Intangible assets |  |  |
Royalty fees included in sales and marketing expense | $ 2,119 | $ 1,661 | $ 1,195
License Agreements |  |  |
Intangible assets |  |  |
Notice period for termination of license agreements | 60 days |  |
Minimum royalty of agreements | $ 13 |  |
Milestone fee upon receiving a Phase II Small Business Innovation Research | 15 |  |
Milestone fee upon FDA approval | 2 |  |
Milestone fee upon first commercial use of certain licensed technology | 25 |  |
Milestone fee upon first use to manufacture products that utilize certain technology not currently incorporated into AxoGen products | $ 10 |  |
License Agreements | Minimum |  |  |
Intangible assets |  |  |
Royalty fees range under the license agreements | 1.00% |  |
License Agreements | Maximum |  |  |
Intangible assets |  |  |
Royalty fees range under the license agreements | 3.00% |  |
Royalty stack cap for royalties paid to more than one licensor for sales of the same product | 3.75% |  |

X
- Definition Represents the amount of milestone payment due if AxoGen receives FDA approval of its Avance Nerve Graft. + References No definition available. + Details
Name: | axgn_MilestonePaymentContingentUponFDApproval
Namespace Prefix: | axgn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the amount of milestone payment due upon first commercial use of certain licensed technology to provide services to manufacture products for third parties. + References No definition available. + Details
Name: | axgn_MilestonePaymentContingentUponFirstCommercialUseOfCertainLicensedTechnology
Namespace Prefix: | axgn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the amount of milestone payment due upon first use to manufacture products that utilize certain technology that is not currently incorporated into AxoGen products. + References No definition available. + Details
Name: | axgn_MilestonePaymentContingentUponFirstUseToManufactureProductsUtilizingCertainTechnology
Namespace Prefix: | axgn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the amount of milestone payment due if the reporting entity receives a grant under one of the grants specified in the license agreement. + References No definition available. + Details
Name: | axgn_MilestonePaymentContingentUponReceiptOfGrant
Namespace Prefix: | axgn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Minimum quarterly royalty required under the terms of one of the reporting entity's licensing arrangements. + References No definition available. + Details
Name: | axgn_MinimumRoyaltyOfLicenseAgreement
Namespace Prefix: | axgn_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Notice period for termination of license agreements. + References No definition available. + Details
Name: | axgn_NoticePeriodForTerminationOfLicenseAgreements
Namespace Prefix: | axgn_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The maximum percentage of royalty which may be paid for the sale of the same product, pursuant to a capping arrangement in the license agreements. + References No definition available. + Details
Name: | axgn_PercentageOfCappingRoyaltiesForMultipleRoyaltyPaymentsToLicensors
Namespace Prefix: | axgn_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalty fees percentage under license agreements. + References No definition available. + Details
Name: | axgn_RoyaltyFeesPercentageUnderLicenseAgreements
Namespace Prefix: | axgn_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.3) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 + Details
Name: | us-gaap_RoyaltyExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |